Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX9QEE
|
||||
| Drug Name |
4-Methyl-2-(5-phenyl-pyridin-3-yl)-pentanoic acid cyanomethyl-amide
|
||||
| Synonyms |
CHEMBL121807
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H21N3O
|
||||
| Canonical SMILES |
CC(C)CC(C(=O)NCC#N)c1cncc(c1)c2ccccc2
|
||||
| InChI |
InChI=1S/C19H21N3O/c1-14(2)10-18(19(23)22-9-8-20)17-11-16(12-21-13-17)15-6-4-3-5-7-15/h3-7,11-14,18H,9-10H2,1-2H3,(H,22,23)
|
||||
| InChIKey |
JIGGOBDMVDMNHC-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.